IBDEI2WH ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46262,1,3,0)
 ;;=3^Subluxation of Lens,Left Eye
 ;;^UTILITY(U,$J,358.3,46262,1,4,0)
 ;;=4^H27.112
 ;;^UTILITY(U,$J,358.3,46262,2)
 ;;=^5005370
 ;;^UTILITY(U,$J,358.3,46263,0)
 ;;=T85.22XA^^176^2303^27
 ;;^UTILITY(U,$J,358.3,46263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46263,1,3,0)
 ;;=3^Displacement of IOL,Init Encntr
 ;;^UTILITY(U,$J,358.3,46263,1,4,0)
 ;;=4^T85.22XA
 ;;^UTILITY(U,$J,358.3,46263,2)
 ;;=^5055529
 ;;^UTILITY(U,$J,358.3,46264,0)
 ;;=H25.813^^176^2303^6
 ;;^UTILITY(U,$J,358.3,46264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46264,1,3,0)
 ;;=3^Cataract,Combined Nucl/Cortical,Bilateral
 ;;^UTILITY(U,$J,358.3,46264,1,4,0)
 ;;=4^H25.813
 ;;^UTILITY(U,$J,358.3,46264,2)
 ;;=^5005293
 ;;^UTILITY(U,$J,358.3,46265,0)
 ;;=Z48.810^^176^2303^12
 ;;^UTILITY(U,$J,358.3,46265,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46265,1,3,0)
 ;;=3^Aftercare Following EYE Surgery
 ;;^UTILITY(U,$J,358.3,46265,1,4,0)
 ;;=4^Z48.810
 ;;^UTILITY(U,$J,358.3,46265,2)
 ;;=^5063047
 ;;^UTILITY(U,$J,358.3,46266,0)
 ;;=H26.109^^176^2303^22
 ;;^UTILITY(U,$J,358.3,46266,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46266,1,3,0)
 ;;=3^Retained Lens Fragments in Eye s/p Surgery,Unspec Eye
 ;;^UTILITY(U,$J,358.3,46266,1,4,0)
 ;;=4^H26.109
 ;;^UTILITY(U,$J,358.3,46266,2)
 ;;=^5133478
 ;;^UTILITY(U,$J,358.3,46267,0)
 ;;=H20.00^^176^2304^1
 ;;^UTILITY(U,$J,358.3,46267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46267,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute NEC
 ;;^UTILITY(U,$J,358.3,46267,1,4,0)
 ;;=4^H20.00
 ;;^UTILITY(U,$J,358.3,46267,2)
 ;;=^5005133
 ;;^UTILITY(U,$J,358.3,46268,0)
 ;;=H20.051^^176^2304^12
 ;;^UTILITY(U,$J,358.3,46268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46268,1,3,0)
 ;;=3^Hypopyon,Right Eye
 ;;^UTILITY(U,$J,358.3,46268,1,4,0)
 ;;=4^H20.051
 ;;^UTILITY(U,$J,358.3,46268,2)
 ;;=^5005150
 ;;^UTILITY(U,$J,358.3,46269,0)
 ;;=H20.052^^176^2304^13
 ;;^UTILITY(U,$J,358.3,46269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46269,1,3,0)
 ;;=3^Hypopyon,Left Eye
 ;;^UTILITY(U,$J,358.3,46269,1,4,0)
 ;;=4^H20.052
 ;;^UTILITY(U,$J,358.3,46269,2)
 ;;=^5005151
 ;;^UTILITY(U,$J,358.3,46270,0)
 ;;=B00.52^^176^2304^6
 ;;^UTILITY(U,$J,358.3,46270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46270,1,3,0)
 ;;=3^Herpes Viral Keratitis
 ;;^UTILITY(U,$J,358.3,46270,1,4,0)
 ;;=4^B00.52
 ;;^UTILITY(U,$J,358.3,46270,2)
 ;;=^5000474
 ;;^UTILITY(U,$J,358.3,46271,0)
 ;;=B00.51^^176^2304^7
 ;;^UTILITY(U,$J,358.3,46271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46271,1,3,0)
 ;;=3^Herpes Viral Iridocyclitis
 ;;^UTILITY(U,$J,358.3,46271,1,4,0)
 ;;=4^B00.51
 ;;^UTILITY(U,$J,358.3,46271,2)
 ;;=^5000473
 ;;^UTILITY(U,$J,358.3,46272,0)
 ;;=B00.59^^176^2304^8
 ;;^UTILITY(U,$J,358.3,46272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46272,1,3,0)
 ;;=3^Herpes Viral Eye Disease NEC
 ;;^UTILITY(U,$J,358.3,46272,1,4,0)
 ;;=4^B00.59
 ;;^UTILITY(U,$J,358.3,46272,2)
 ;;=^5000476
 ;;^UTILITY(U,$J,358.3,46273,0)
 ;;=B02.33^^176^2304^9
 ;;^UTILITY(U,$J,358.3,46273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46273,1,3,0)
 ;;=3^Herpes Zoster Keratitis
 ;;^UTILITY(U,$J,358.3,46273,1,4,0)
 ;;=4^B02.33
 ;;^UTILITY(U,$J,358.3,46273,2)
 ;;=^5000496
 ;;^UTILITY(U,$J,358.3,46274,0)
 ;;=B02.32^^176^2304^10
 ;;^UTILITY(U,$J,358.3,46274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46274,1,3,0)
 ;;=3^Herpes Zoster Iridocyclitis
